{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:14:31Z","timestamp":1776978871749,"version":"3.51.4"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>The incidence of cervical adenocarcinoma, both absolute and relative to squamous cell carcinoma, is increasing. Most cervical adenocarcinomas are human papillomavirus associated, although non\u2013human papillomavirus-associated neoplasms exist; the latter include gastric-type adenocarcinoma (GAS) and clear cell carcinoma (CCC). Histologically, these 2 tumors may superficially resemble one other and although morphologic evaluation usually permits a correct diagnosis, immunohistochemistry may be required to resolve diagnostic uncertainty, especially in a small biopsy specimen. Markers of CCC include hepatocyte nuclear factor 1 beta (HNF1\u03b2) and Napsin A. In order to explore the utility of these markers in distinguishing between GAS and CCC, we stained 24 cases of GAS (19 cervical, 5 vaginal), 3 of cervical gastric-type adenocarcinoma in situ (gAIS) and 14 CCCs (13 cervical, 1 vaginal) with these antibodies. We found HNF1\u03b2 expression in 21 of 23 cases of GAS (91.3%; there was no material available for staining in 1 case), 3\/3 cases of gAIS (100%) and 10 of 14 (71.4%) CCCs. Napsin A was expressed in 4 of 24 (16.7%) cases of GAS, 0 of 3 (0%) gAIS, and 11 of 14 (78.6%) CCC. On the basis of these findings, Napsin A is of value in resolving diagnostic confusion between GAS and CCC, whereas HNF1\u03b2 lacks specificity and its use in this setting is discouraged.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000529","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T17:07:00Z","timestamp":1528823220000},"page":"276-282","source":"Crossref","is-referenced-by-count":24,"title":["Expression of Markers of M\u00fcllerian Clear Cell Carcinoma in Primary Cervical and Vaginal Gastric-type Adenocarcinomas"],"prefix":"10.1097","volume":"38","author":[{"given":"Karen L.","family":"Talia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Wing-Cheuk","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2014a 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R2-20230824","first-page":"645","article-title":"Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix\u2014worldwide","volume":"10","author":"Mathew","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"R3-20230824","first-page":"1151","article-title":"Cervical cancer: The increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women","volume":"164","author":"Shiliang","year":"2001","journal-title":"CMAJ"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/jwh.2011.3385","article-title":"Cervical cancer trends in the United States: a 35-year population-based analysis","volume":"21","author":"Adegoke","year":"2012","journal-title":"J Womens Health"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/1471-2407-13-553","article-title":"Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination","volume":"13","author":"Pimenta","year":"2013","journal-title":"BMC Cancer"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","article-title":"HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases","volume":"27","author":"Pirog","year":"2014","journal-title":"Mod Pathol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/ijc.29651","article-title":"Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study","volume":"137","author":"Holl","year":"2015","journal-title":"Int J Cancer"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pathol.2017.09.009","article-title":"The developing spectrum of gastric-type cervical glandular lesions","volume":"50","author":"Talia","year":"2018","journal-title":"Pathology"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2559.2001.01239.x","article-title":"Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype","volume":"39","author":"Mikami","year":"2001","journal-title":"Histopathology"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/modpathol.3800148","article-title":"Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia\/pyloric gland metaplasia and \u2018adenoma malignum\u2019","volume":"17","author":"Mikami","year":"2004","journal-title":"Mod Pathol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/01.pas.0000213434.91868.b0","article-title":"Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix","volume":"31","author":"Kojima","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/PAS.0b013e3181883722","article-title":"Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study","volume":"32","author":"Kawauchi","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2353\/ajpath.2010.100323","article-title":"Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype","volume":"177","author":"Kusanagi","year":"2010","journal-title":"Am J Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAP.0b013e31829c2d66","article-title":"Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant and malignant lesions","volume":"20","author":"Mikami","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/PAS.0000000000000532","article-title":"Gastric-type endocervical adenocarcinoma. An aggressive tumour with unusual metastatic patterns and poor prognosis","volume":"39","author":"Karamurzin","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/PAT.0000000000000329","article-title":"Foamy gland changes in gastric-type endocervical neoplasia","volume":"47","author":"Stewart","year":"2015","journal-title":"Pathology"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/PAP.0000000000000095","article-title":"Recent developments in non-HPV-related adenocarcinomas of the lower female genital tract and their precursors","volume":"23","author":"McCluggage","year":"2016","journal-title":"Adv Anat Pathol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0000000000000578","article-title":"A detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas","volume":"40","author":"Carleton","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/PAS.0000000000000855","article-title":"HPV-negative gastric type adenocarcinoma in situ of the cervix: a spectrum of rare lesions exhibiting gastric and intestinal differentiation","volume":"41","author":"Talia","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/PGP.0b013e31822c8036","article-title":"Primary vaginal mucinous adenocarcinoma of gastric type arising in adenosis: a report of 2 cases, 1 associated with uterus didelphys","volume":"31","author":"Talia","year":"2012","journal-title":"Int J Gynaecol Pathol"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/PGP.0000000000000430","article-title":"Morphologic and immunohistochemical study of clear cell carcinoma of the uterine endometrium and cervix in comparison to ovarian clear cell carcinoma","volume":"37","author":"Ju","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/PAT.0000000000000223","article-title":"Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours","volume":"47","author":"Fadare","year":"2015","journal-title":"Pathology"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/modpathol.2008.95","article-title":"Clear cell carcinoma of the pancreas: histopathologic features and a unique biomarker: hepatocyte nuclear factor-1beta","volume":"21","author":"Kim","year":"2008","journal-title":"Mod Pathol"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2559.2012.04267.x","article-title":"Utility of hepatocyte nuclear factor-1beta as a diagnostic marker in ovarian carcinomas with clear cells","volume":"61","author":"Kao","year":"2012","journal-title":"Histopathology"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/PAS.0000000000000436","article-title":"Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma","volume":"39","author":"Lim","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAP.0000000000000069","article-title":"Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry","volume":"22","author":"Conner","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/his.12383","article-title":"Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin","volume":"65","author":"Kim","year":"2014","journal-title":"Histopathology"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13000-015-0242-z","article-title":"Immunoexpression of napsin A in renal neoplasms","volume":"10","author":"Zhu","year":"2015","journal-title":"Diagn Pathol"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humpath.2015.03.008","article-title":"Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium","volume":"46","author":"Iwamoto","year":"2015","journal-title":"Hum Pathol"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1309\/AJCP8WO2EOIAHSOF","article-title":"The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary","volume":"142","author":"Kandalaft","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/modpathol.2014.61","article-title":"Napsin A is a specific marker for ovarian clear cell adenocarcinoma","volume":"28","author":"Yamashita","year":"2015","journal-title":"Mod Pathol"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/jcp.2010.080150","article-title":"Composite cervical adenocarcinoma composed of adenoma malignum and gastric type adenocarcinoma (dedifferentiated adenoma malignum) in a patient with Peutz Jeghers syndrome","volume":"63","author":"McCluggage","year":"2010","journal-title":"J Clin Pathol"},{"key":"R35-20230824","first-page":"11798","article-title":"Gastric-type mucinous adenocarcinoma of the uterine cervix with neoadjuvant therapy mimicking clear cell carcinoma","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM197104222841604","article-title":"Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women","volume":"284","author":"Herbst","year":"1971","journal-title":"N Eng J Med"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(197004)25:4<745::AID-CNCR2820250402>3.0.CO;2-2","article-title":"Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas)","volume":"25","author":"Herbst","year":"1970","journal-title":"Cancer"},{"key":"R38-20230824","first-page":"720","article-title":"Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure","volume":"62","author":"Kaminski","year":"1983","journal-title":"Obstet Gynecol"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00004347-200107000-00008","article-title":"Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract","volume":"20","author":"Vang","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.PGP.0000071044.12278.43","article-title":"A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma","volume":"22","author":"Cameron","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0b013e3181ff400e","article-title":"Morphologic spectrum of immunohistochemically characterised clear cell carcinoma of the ovary: a study of 155 cases","volume":"35","author":"DeLair","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R42-20230824","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","article-title":"Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma","volume":"163","author":"Tsuchiya","year":"2003","journal-title":"Am J Pathol"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/modpathol.3800492","article-title":"Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary","volume":"19","author":"Kato","year":"2006","journal-title":"Mod Pathol"},{"key":"R44-20230824","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.humpath.2006.12.018","article-title":"Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium","volume":"38","author":"Yamamoto","year":"2007","journal-title":"Hum Pathol"},{"key":"R45-20230824","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/PGP.0b013e318273fd07","article-title":"HNF-1\u03b2 in ovarian carcinomas with serous and clear cell change","volume":"32","author":"DeLair","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"R46-20230824","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PAI.0b013e31824973d1","article-title":"Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma","volume":"20","author":"Fadare","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R47-20230824","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/PAS.0b013e31821534b9","article-title":"Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus","volume":"35","author":"Park","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R48-20230824","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000085","article-title":"Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility","volume":"38","author":"Fadare","year":"2014","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201905000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:36:03Z","timestamp":1692840963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201905000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000529","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}